doi: 10.1001/jama.260.7.971 144 StrausSEDaleJKTobiMLawleyTPrebleOBlaeseRMet al
Clin Orthop Relat Res 316 : 151164 Ohberg L et al
Look for manufacturing under GMP with ISO/IEC 17025accredited thirdparty verification and transparent method reporting
Twelve of these genes (KRT1, CBR1, ALDOB, AHNAK, CSRP1, DHRS7 FABP5, NEFL, CRABP2, CALD1, RIMS1, and ALB) had the most significant expression differences, and then a prognostic model was constructed focusing on 6 genes, with DHRS7 finally determined as the primary gene for subsequent study
Finally, we solicited feedback from interested parties on the importance, relevance, and applicability of a cross-setting functional outcome measure for LTCHs through an RFI in the FY 2023 LTCH PPS proposed rule (87 FR 28568)